These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34626534)

  • 1. SPRED2 loss-of-function causes a recessive Noonan syndrome-like phenotype.
    Motta M; Fasano G; Gredy S; Brinkmann J; Bonnard AA; Simsek-Kiper PO; Gulec EY; Essaddam L; Utine GE; Guarnetti Prandi I; Venditti M; Pantaleoni F; Radio FC; Ciolfi A; Petrini S; Consoli F; Vignal C; Hepbasli D; Ullrich M; de Boer E; Vissers LELM; Gritli S; Rossi C; De Luca A; Ben Becher S; Gelb BD; Dallapiccola B; Lauri A; Chillemi G; Schuh K; Cavé H; Zenker M; Tartaglia M
    Am J Hum Genet; 2021 Nov; 108(11):2112-2129. PubMed ID: 34626534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal recessive Noonan-like syndrome caused by homozygosity for a previously unreported variant in SPRED2.
    Markholt S; Andreasen L; Bjerre J; Gregersen PA; Andersen BN
    Eur J Med Genet; 2023 Feb; 66(2):104695. PubMed ID: 36608738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Homozygous Loss-of-Function Variant in
    Onore ME; Caiazza M; Farina A; Scarano G; Budillon A; Borrelli RN; Limongelli G; Nigro V; Piluso G
    Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ribosomal S6 kinase 2 (RSK2)-SPRED2 complex regulates the phosphorylation of RSK substrates and MAPK signaling.
    Lopez J; Bonsor DA; Sale MJ; Urisman A; Mehalko JL; Cabanski-Dunning M; Castel P; Simanshu DK; McCormick F
    J Biol Chem; 2023 Jun; 299(6):104789. PubMed ID: 37149146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome.
    Tartaglia M; Pennacchio LA; Zhao C; Yadav KK; Fodale V; Sarkozy A; Pandit B; Oishi K; Martinelli S; Schackwitz W; Ustaszewska A; Martin J; Bristow J; Carta C; Lepri F; Neri C; Vasta I; Gibson K; Curry CJ; Siguero JP; Digilio MC; Zampino G; Dallapiccola B; Bar-Sagi D; Gelb BD
    Nat Genet; 2007 Jan; 39(1):75-9. PubMed ID: 17143282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss-of-function variants in ERF are associated with a Noonan syndrome-like phenotype with or without craniosynostosis.
    Dentici ML; Niceta M; Lepri FR; Mancini C; Priolo M; Bonnard AA; Cappelletti C; Leoni C; Ciolfi A; Pizzi S; Cordeddu V; Rossi C; Ferilli M; Mucciolo M; Colona VL; Fauth C; Bellini M; Biasucci G; Sinibaldi L; Briuglia S; Gazzin A; Carli D; Memo L; Trevisson E; Schiavariello C; Luca M; Novelli A; Michot C; Sweertvaegher A; Germanaud D; Scarano E; De Luca A; Zampino G; Zenker M; Mussa A; Dallapiccola B; Cavé H; Digilio MC; Tartaglia M
    Eur J Hum Genet; 2024 Aug; 32(8):954-963. PubMed ID: 38824261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants of SOS2 are a rare cause of Noonan syndrome with particular predisposition for lymphatic complications.
    Lissewski C; Chune V; Pantaleoni F; De Luca A; Capri Y; Brinkmann J; Lepri F; Daniele P; Leenders E; Mazzanti L; Scarano E; Radio FC; Kutsche K; Kuechler A; Gérard M; Ranguin K; Legendre M; Vial Y; van der Burgt I; Rinne T; Andreucci E; Mastromoro G; Digilio MC; Cave H; Tartaglia M; Zenker M
    Eur J Hum Genet; 2021 Jan; 29(1):51-60. PubMed ID: 32788663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum.
    Motta M; Pannone L; Pantaleoni F; Bocchinfuso G; Radio FC; Cecchetti S; Ciolfi A; Di Rocco M; Elting MW; Brilstra EH; Boni S; Mazzanti L; Tamburrino F; Walsh L; Payne K; Fernández-Jaén A; Ganapathi M; Chung WK; Grange DK; Dave-Wala A; Reshmi SC; Bartholomew DW; Mouhlas D; Carpentieri G; Bruselles A; Pizzi S; Bellacchio E; Piceci-Sparascio F; Lißewski C; Brinkmann J; Waclaw RR; Waisfisz Q; van Gassen K; Wentzensen IM; Morrow MM; Álvarez S; Martínez-García M; De Luca A; Memo L; Zampino G; Rossi C; Seri M; Gelb BD; Zenker M; Dallapiccola B; Stella L; Prada CE; Martinelli S; Flex E; Tartaglia M
    Am J Hum Genet; 2020 Sep; 107(3):499-513. PubMed ID: 32721402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OCD-like behavior is caused by dysfunction of thalamo-amygdala circuits and upregulated TrkB/ERK-MAPK signaling as a result of SPRED2 deficiency.
    Ullrich M; Weber M; Post AM; Popp S; Grein J; Zechner M; Guerrero González H; Kreis A; Schmitt AG; Üçeyler N; Lesch KP; Schuh K
    Mol Psychiatry; 2018 Feb; 23(2):444-458. PubMed ID: 28070119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular genetics of RASopathies: An update on novel disease genes and new disorders.
    Tartaglia M; Aoki Y; Gelb BD
    Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):425-439. PubMed ID: 36394128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome.
    Aoki Y; Niihori T; Banjo T; Okamoto N; Mizuno S; Kurosawa K; Ogata T; Takada F; Yano M; Ando T; Hoshika T; Barnett C; Ohashi H; Kawame H; Hasegawa T; Okutani T; Nagashima T; Hasegawa S; Funayama R; Nagashima T; Nakayama K; Inoue S; Watanabe Y; Ogura T; Matsubara Y
    Am J Hum Genet; 2013 Jul; 93(1):173-80. PubMed ID: 23791108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noonan syndrome gain-of-function mutations in NRAS cause zebrafish gastrulation defects.
    Runtuwene V; van Eekelen M; Overvoorde J; Rehmann H; Yntema HG; Nillesen WM; van Haeringen A; van der Burgt I; Burgering B; den Hertog J
    Dis Model Mech; 2011 May; 4(3):393-9. PubMed ID: 21263000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased BRAF heterodimerization is the common pathogenic mechanism for noonan syndrome-associated RAF1 mutants.
    Wu X; Yin J; Simpson J; Kim KH; Gu S; Hong JH; Bayliss P; Backx PH; Neel BG; Araki T
    Mol Cell Biol; 2012 Oct; 32(19):3872-90. PubMed ID: 22826437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities.
    Gilbert-Dussardier B; Briand-Suleau A; Laurendeau I; Bilan F; Cavé H; Verloes A; Vidaud M; Vidaud D; Pasmant E
    Orphanet J Rare Dis; 2016 Jul; 11(1):101. PubMed ID: 27450488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-generation sequencing identifies rare variants associated with Noonan syndrome.
    Chen PC; Yin J; Yu HW; Yuan T; Fernandez M; Yung CK; Trinh QM; Peltekova VD; Reid JG; Tworog-Dube E; Morgan MB; Muzny DM; Stein L; McPherson JD; Roberts AE; Gibbs RA; Neel BG; Kucherlapati R
    Proc Natl Acad Sci U S A; 2014 Aug; 111(31):11473-8. PubMed ID: 25049390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noonan syndrome-like phenotype associated with an ERF frameshift variant.
    Hirano Y; Kuroda Y; Enomoto Y; Naruto T; Muroya K; Kurosawa K
    Am J Med Genet A; 2024 Sep; 194(9):e63652. PubMed ID: 38741564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activating MRAS mutations cause Noonan syndrome associated with hypertrophic cardiomyopathy.
    Motta M; Sagi-Dain L; Krumbach OHF; Hahn A; Peleg A; German A; Lissewski C; Coppola S; Pantaleoni F; Kocherscheid L; Altmüller F; Schanze D; Logeswaran T; Chahrokh-Zadeh S; Munzig A; Nakhaei-Rad S; Cavé H; Ahmadian MR; Tartaglia M; Zenker M
    Hum Mol Genet; 2020 Jul; 29(11):1772-1783. PubMed ID: 31108500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spred2 Regulates High Fat Diet-Induced Adipose Tissue Inflammation, and Metabolic Abnormalities in Mice.
    Ohkura T; Yoshimura T; Fujisawa M; Ohara T; Marutani R; Usami K; Matsukawa A
    Front Immunol; 2019; 10():17. PubMed ID: 30723473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Craniosynostosis in patients with RASopathies: Accumulating clinical evidence for expanding the phenotype.
    Ueda K; Yaoita M; Niihori T; Aoki Y; Okamoto N
    Am J Med Genet A; 2017 Sep; 173(9):2346-2352. PubMed ID: 28650561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.
    Witkowski L; Dillon MW; Murphy E; S Lebo M; Mason-Suares H
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1180. PubMed ID: 32107864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.